Overall, both reports reinforce our current and previous (5) notion that chronic low-grade inflammation seems to be an important risk factor in SSc patients and that SSc patients with sustained CRP elevations should be classified as a separate “inflammatory” SSc phenotype. The gene discussed is CRP; the disease is systemic sclerosis.